Scarica l'app Stockscreener
5.03
5.01%
0.24
Neonc Technologies Holdings Inc Borsa (NTHI) Ultime notizie
NeOnc Technologies (NASDAQ: NTHI) names Shomali to audit panel - Stock Titan
Neonc Technologies CEO Thomas C. Chen acquires $70,010 of common shares via IRA - Bitget
NeOnc Technologies Holds 2026 Annual Stockholder Meeting - The Globe and Mail
Neonc Technologies CEO Thomas Chen buys $69,997 in stock - Investing.com
Neonc Technologies CSO Thomas Chen buys $192,899 in stock - Investing.com
NeOnc Technologies (NTHI) CEO adds 12.8K-share IRA stake - Stock Titan
NeOnc Technologies (NTHI) investors approve equity plan, elect two directors - Stock Titan
Founder of NeOnc Technologies Holdings Thomas Chen Buys 1.0% More Shares - simplywall.st
NeOnc Technologies- Talk Is Cheap, Insider Buying Isn’t - Sahm
NeOnc Technologies (NTHI) CEO boosts stake with August open‑market buys - Stock Titan
Neonc Technologies CEO Amir Heshmatpour acquires $49,860 in stock - Investing.com
Neonc Technologies CEO Amir Heshmatpour acquires $49,860 in stock By Investing.com - Investing.com Canada
NeOnc (NTHI) CEO lifts direct stake to 3,096,000 shares - Stock Titan
NeOnc Technologies Holdings CEO Continues Open-Market Buying Following NEO100 Phase 2a Results and Elevated Short Interest - Quiver Quantitative
Neonc Technologies CEO buys $58,579 in company shares By Investing.com - Investing.com Australia
NTHI’s Nasdaq Advantage Takes on New Meaning After Its Breakthrough Phase 2a Results - Sahm
Neonc Technologies CEO buys $58,579 in company shares - Investing.com
NeOnc Technologies (NTHI) CEO adds stock in two August buys - Stock Titan
NeOnc Technologies Holdings, Inc. Common Stock (NASDAQ: NTHI) Stock Price, News & Analysis - Kalkine
Duos Technologies Group Sets Second Quarter 2026 Earnings Call for Monday, August 17, 2026 at 4:30 PM ET - Stocktwits
NeOnc Technologies Holdings' Phase 2a Results Strengthen the Case for Its Nasdaq-Backed Capital Strategy - Moomoo
NeOnc Technologies Holdings’ Phase 2a Results Strengthen the Case for Its Nasdaq-Backed Capital Strategy - Quiver Quantitative
NTHI's Nasdaq Advantage Takes on New Meaning After Its Breakthrough Phase 2a Results - Moomoo
NeOnc Technologies Holdings Inc (NTHI) (Q2 2026) Earnings Call Highlights: First Annual Meeting ... By GuruFocus - Investing.com Canada
NTHI: All proposals, including director elections and plan amendments, were approved without questions - TradingView
Maxim Group Maintains NeOnc Technologies(NTHI.US) With Buy Rating, Maintains Target Price $20 - Moomoo
NeOnc Reports 26.1-Month Median Overall Survival in Phase 2a Brain Cancer Trial - Minichart
NeOnc Technologies holds investor call to discuss Phase 2a NEO100-01 results By Investing.com - Investing.com Nigeria
Form 8K Neonc Technologies Holdings Inc For: 13 August By Investing.com - Investing.com Canada
NeOnc Technologies (NTHI) NEO100 Phase 2a Readout Clears Primary Endpoint, FDA Meeting Planned - kalkine.ca
The Nose Knows: Why NeOnc’s Patent Portfolio Could Make NTHI More Than a One-Drug Biotech - The Manila Times
NeOnc Technologies Holdings’ NEO100 Phase 2a Results Highlight Intranasal Brain-Delivery Platform Potential - Quiver Quantitative
NeOnc's Nasal Drug Delivery Strategy Reached a Brain-Cancer Trial - Stock Titan
Why is Neonc Technologies stock surging today? By Investing.com - Investing.com South Africa
Targeting The Mutant: NTHI’s NEO100 Data Could Open a New Front in the Fight Against Brain Cancer - The Manila Times
NeOnc Technologies Holdings Reports Positive Phase 2a Results for Intranasal NEO100 in Recurrent IDH1-Mutant High-Grade Glioma - Quiver Quantitative
NeOnc Technologies stock jumps on positive glioma trial data By Investing.com - Investing.com Australia
NeOnc Technologies shares jump after positive Phase 2a glioma results - Yahoo Finance
NeOnc's NEO100 Phase 2a Brain Cancer Study Beats Historical Benchmark by Nearly 2.5x - Yahoo Finance
Why is Neonc Technologies stock surging today? - Investing.com
$NeOnc Technologies (NTHI.US)$ $NTHI plans an FDA Type B meeting to align the registrational path, signaling trial for accelerated approval. Clinical breakthrough could unlock financing and partnerships for NTHI's funding, milestone payments and markers - Moomoo
NeOnc Technologies Reports Positive Phase 2a Glioma Results - TipRanks
Form 8K Neonc Technologies Holdings Inc For: 12 August By Investing.com - Investing.com India
NeOnc reports phase 2a glioma trial meets primary endpoint By Investing.com - Investing.com Australia
NeOnc reports phase 2a glioma trial meets primary endpoint - Investing.com
$NTHI Mr. Heshmatpour CEO invested nearly $1 million of personal capital into NeOnc shares. In recent Months, he has purchased over $500,000 in the open market, as reflected in Form 4 filings with the U.S. Securities and Exchange Commission, with furthe - Moomoo
NeOnc Technologies stock jumps on positive glioma trial data - Investing.com
NeOnc Technologies Reports Positive Phase 2a NEO100 Results; Median OS 26.09 Months, PFS-6 48.9% - TradingView
Why is NeOnc Technologies stock surging today? By Investing.com - Investing.com Canada
NeOnc Technologies Reports Positive Topline Phase 2a Results for Intranasal NEO100 in Recurrent IDH1-Mutant High-Grade Glioma - The Manila Times
0.86%
0.31%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):